Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05778409Phase 1Completed
Phase 1, randomised, double-blind trial (2 arms), sponsored by China Medical University Hospital. Primary endpoints: Ocular Surface Disease Index at 1 month and Best Corrected Visual Acuity at 1 month. Started Mar 2023; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05778409.